Nitric oxide and breast cancer disease progression: Role of timp-1 in pro-survival signaling
Lisa A. Ridnour(National Institutes of Health), Chris Switzer, Stephan Ambs, Sneha Dhanapal, David A. Wink(National Cancer Institute), Harris G. Yfantis(University of Maryland, Baltimore), Mike Lizardo, Tiffany H. Dorsey(Center for Cancer Research), Julie L. Heinecke(National Cancer Institute), Kim Barasch, Harry B. Hines(United States Army Medical Research Institute of Infectious Diseases), Alisha N. Windhausen(National Cancer Institute), Ernie Brueggemann, Chand Khanna(Drug Discovery Laboratory (Norway)), Dong Hoon Lee(Korea University), Sharon A. Glynn(Ollscoil na Gaillimhe – University of Galway)
Cited by 0
Related Papers
Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer
|Cancer Research|2008|708
The multifaceted roles of nitric oxide in cancer
|Carcinogenesis|1998|682
“NONOates” (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: Convenient nitric oxide dosage forms
|Methods in enzymology on CD-ROM/Methods in enzymology|1996|674